ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 182 filers reported holding ASCENDIS PHARMA A/S in Q1 2022. The put-call ratio across all filers is 0.64 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,404 | +4.9% | 15 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $1,338 | -16.8% | 15 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $1,608 | -11.2% | 15 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $1,810 | +81.0% | 15 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $1,000 | 0.0% | 15 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $1,000 | -50.0% | 15 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $2,000 | 0.0% | 15 | -16.7% | 0.00% | 0.0% |
| Q4 2021 | $2,000 | -33.3% | 18 | -5.3% | 0.00% | -50.0% |
| Q3 2021 | $3,000 | +50.0% | 19 | 0.0% | 0.00% | +100.0% |
| Q2 2021 | $2,000 | -33.3% | 19 | -9.5% | 0.00% | -50.0% |
| Q1 2021 | $3,000 | -25.0% | 21 | -12.5% | 0.00% | 0.0% |
| Q4 2020 | $4,000 | +33.3% | 24 | +9.1% | 0.00% | 0.0% |
| Q3 2020 | $3,000 | 0.0% | 22 | 0.0% | 0.00% | -33.3% |
| Q2 2020 | $3,000 | 0.0% | 22 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $3,000 | +50.0% | 22 | +100.0% | 0.00% | +50.0% |
| Q4 2019 | $2,000 | – | 11 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 5,865,338 | $978,221,000 | 13.68% |
| Vivo Capital, LLC | 1,797,745 | $299,828,000 | 13.38% |
| Sofinnova Investments, Inc. | 1,109,874 | $185,105,000 | 11.02% |
| Avoro Capital Advisors LLC | 1,800,000 | $300,204,000 | 5.17% |
| Eventide Asset Management | 1,704,148 | $284,218,000 | 4.36% |
| Stenahm Asset Managment Ltd | 29,000 | $4,837,000 | 4.07% |
| Ghost Tree Capital, LLC | 105,000 | $17,512,000 | 3.90% |
| Eversept Partners, LP | 187,043 | $31,195,032 | 3.66% |
| Spyglass Capital Management LLC | 701,594 | $117,012,000 | 3.59% |
| Q Global Advisors, LLC | 23,183 | $3,866,000 | 2.72% |